Clinical Trials Directory

Trials / Unknown

UnknownNCT05869357

Safety of Cream Containing Sericin and Turmeric in Healthy Volunteers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
106 (estimated)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The object of this study was to evaluate safety of cream containing sericin and turmeric in healthy volunteers.

Detailed description

There are 106 healthy volunteers in this study. Upper left arm is divided into 2 parts (2x2 cm) which are A and B area. Upper right arm is divided into 2 parts (2x2 cm) which are C and D area. Four area (A, B, C, and D) are randomized to receive cream containing 2.5% sericin and 2%turmeric, cream containing 5%sericin and 2%turmeric, cream containing 10%sericin and 2%turmeric, and cream base (Control group). Samples are applied 2 times/day for 6 days (Induction phase). Then, the volunteers will stop applying samples for 7 to 10 days (Free period). After that, Samples are applied 2 times/day for 3 days (Challenge phase). Erythema, melanin, humidity, transepidermal water loss, skin adverse reaction, and satisfaction are evaluated.

Conditions

Interventions

TypeNameDescription
OTHERcream containing 2.5% sericin and 2%turmericSample is applied 2 times/day for 6 days. Then, use of the sample is stopped for 7 to 10 days. After that, sample is applied 2 times/day for 3days.
OTHERcream containing 5%sericin and 2%turmericSample is applied 2 times/day for 6 days. Then, use of the sample is stopped for 7 to 10 days. After that, sample is applied 2 times/day for 3days.
OTHERcream containing 10%sericin and 2%turmericSample is applied 2 times/day for 6 days. Then, use of the sample is stopped for 7 to 10 days. After that, sample is applied 2 times/day for 3days.
OTHERcream baseSample is applied 2 times/day for 6 days. Then, use of the sample is stopped for 7 to 10 days. After that, sample is applied 2 times/day for 3days.

Timeline

Start date
2023-07-01
Primary completion
2023-10-30
Completion
2023-11-30
First posted
2023-05-22
Last updated
2023-05-24

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT05869357. Inclusion in this directory is not an endorsement.